IBRO Neuroscience Reports (Oct 2023)
HIGHLY POTENT AND SELECTIVE PPAR DELTA AGONIST REVERSES MEMORY DEFICITS IN ALZHEIMER'S DISEASE MOUSE MODELS
- Hyeon Jeong Kim,
- Haelee Kim,
- Jaeyoung Song,
- Jun Young Hong,
- Elijah Lee,
- Ji Won Choi,
- Sun Jun Park,
- Heeseok Yoon,
- Hoosang Hwang,
- Dongyup Hahn,
- Kyungjin Jung,
- Sugyeong Kwon,
- Tara Kadayat,
- Min Jung Ma,
- Jeongmin Joo,
- Jae Hyun Bae,
- Jong-Hyun Park,
- Hayoung Hwang,
- Sung Jin Cho,
- Jungwook Chin,
- Heonjoong Kang,
- Ki Duk Park
Affiliations
- Hyeon Jeong Kim
- Korea Institute of Science and Technology, Center For Brain Disorders, Seoul, Korea, Republic of
- Haelee Kim
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Jaeyoung Song
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Jun Young Hong
- Seoul National University, The Center For Marine Natural Products And Drug Discovery, Seoul, Korea, Republic of
- Elijah Lee
- Korea Institute of Science and Technology, Center For Brain Disorders, Seoul, Korea, Republic of; Korea University of Science and Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Ji Won Choi
- Korea Institute of Science and Technology, Center For Brain Disorders, Seoul, Korea, Republic of
- Sun Jun Park
- Cureverse, lnc, Drug Discovery, Seoul, Korea, Republic of
- Heeseok Yoon
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Hoosang Hwang
- Seoul National University, The Center For Marine Natural Products And Drug Discovery, Seoul, Korea, Republic of
- Dongyup Hahn
- Seoul National University, The Center For Marine Natural Products And Drug Discovery, Seoul, Korea, Republic of; Kyungpook National University, School Of Food Science And Biotechnology, Daegu, Korea, Republic of
- Kyungjin Jung
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Sugyeong Kwon
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Tara Kadayat
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Min Jung Ma
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Jeongmin Joo
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Jae Hyun Bae
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Jong-Hyun Park
- Korea Institute of Science and Technology, Center For Brain Disorders, Seoul, Korea, Republic of; Korea University of Science and Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Hayoung Hwang
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of
- Sung Jin Cho
- Cureverse, lnc, Drug Discovery, Seoul, Korea, Republic of
- Jungwook Chin
- Daegu-Gyeongbuk Medical Innovation Foundation, New Drug Development Center, Daegu, Korea, Republic of; Cureverse, lnc, Drug Discovery, Seoul, Korea, Republic of
- Heonjoong Kang
- Seoul National University, The Center For Marine Natural Products And Drug Discovery, Seoul, Korea, Republic of; Seoul National University, Research Institute Of Oceanography, Seoul, Korea, Republic of
- Ki Duk Park
- Korea Institute of Science and Technology, Center For Brain Disorders, Seoul, Korea, Republic of; Korea University of Science and Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Journal volume & issue
-
Vol. 15
p. S434
